Response to brentuximab vedotin plus CHP according to CD30 expression in the ECHELON-2 trial

BRITISH JOURNAL OF HAEMATOLOGY(2020)

Cited 2|Views51
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined